Live Chat

Berdagang Gilead GILD

Jual
 Beli

Gilead carta live

5m 15m 30m 1h 4h 1d 1w

Asas Instrumen

Weekly Search
Weekly
Daily
Tarikh Tutup Perubahan Perubahan (%): Buka Tinggi Rendah

Berita

Maklumat

Sebaran nilai

0.57

Spread (%)

0.6213 %

Leveraj

1:10

Faedah semalaman (Beli)

-0.0597 %

Faedah semalaman (Jual)

-0.0292 %

Mata wang

USD

Waktu perdagangan

Pasaran ditutup

Jumaat

14:31 - 20:59

Isnin

14:31-20:59

Selasa

14:31-20:59

Rabu

14:31-20:59

Khamis

14:31-20:59

Analisis dan statistik

Buka

---

Tutup Terdahulu

---

Tinggi/Rendah 52 Minggu

--- – ---

Modal pasaran

117585453056

Saham Tertunggak

1246000000

Tarikh Pendapatan (Seterusnya)

2013-01-28

Hasil Div

2024-09-27

Tarikh Selepas Dividen

2024-12-13

Kadar dividen tahunan depan

3.08

Hasil dividen tahunan depan

0.0326

EPS

0.09

Ketahui lebih lanjut mengenai instrumen ini

Gilead Gilead Sciences Inc
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, Sunlencs, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of COVID-19; and Epclusa, Harvoni, Vemlidy, and Viread for the treatment of viral hepatitis. It also offers Yescarta, Tecartus, and Trodelvy products for the treatment of oncology; Letairis, an oral formulation for the treatment of pulmonary arterial hypertension; and AmBisome, a liposomal formulation for the treatment of serious invasive fungal infections. The company has collaboration agreements with Arcus Biosciences, Inc.; Merck Sharp & Dohme Corp.; Pionyr Immunotherapeutics Inc.; Tizona Therapeutics, Inc.; Galapagos NV; Janssen Sciences Ireland Unlimited Company; Japan Tobacco, Inc.; Dragonfly Therapeutics, Inc.; Arcellx, Inc.; Everest Medicines; Merck & Co, Inc.; Tentarix Biotherapeutics Inc.; Marengo Therapeutics; and Assembly Biosciences, Inc. It also has research collaboration, option, and license agreement with Merus N.V. for the discovery of novel dual tumor-associated antigens (TAA) targeting trispecific antibodies. The company was incorporated in 1987 and is headquartered in Foster City, California.

Instrumen Berkaitan

Aset
Jual
Beli
Perubahan (%):

Berdaganglah Sekarang

Berdaganglah Sekarang

Berdaganglah Sekarang

Berdaganglah Sekarang
Instrumen Berkaitan

Berita Terkini

Ketahui perkembangan dengan berita kewangan terkini dari seluruh dunia.

Khamis, 14 November 2024

Dogecoin surges after Elon Musk issues crypto endorsement

Nvidia Blackwell AI Chips

Khamis, 14 November 2024

Week ahead: Tech rally hinges on Nvidia earnings

Dogecoin surges

Rabu, 13 November 2024

Dogecoin surges as Trump unveils new government efficiency initiative with Musk andRamaswamy

Rabu, 13 November 2024

Japanese Yen to USD: Yen drops to fresh multi-month low against USD

Rabu, 13 November 2024

Asia markets today: Nikkei 225 up 0.18%, Hang Seng Index falls by 197 points

Selasa, 12 November 2024

UK stock market news: Helium One share price trading 16.1% higher

Selasa, 12 November 2024

Leveraged ETF to package Warren Buffett's Berkshire Hathaway B stock

Selasa, 12 November 2024

Dogecoin surges 20% after Department of Government Efficiency announcement

Lihat semua berita
Trustpilot
Live Chat